Rapid Scanning Structure-Activity Relationships in Combinatorial Data Sets: Identification of Activity Switches

We present a general approach to describe the structure-activity relationships (SAR) of combinatorial data sets with activity for two biological endpoints with emphasis on the rapid identification of substitutions that have a large impact on activity and selectivity. The approach uses dual-activity difference (DAD) maps that represent a visual and quantitative analysis of all pairwise comparisons of one, two, or more substitutions around a molecular template. Scanning the SAR of data sets using DAD maps allows the visual and quantitative identification of activity switches defined as specific substitutions that have an opposite effect on the activity of the compounds against two targets. The approach also rapidly identifies single- and double-target R-cliffs, i.e., compounds where a single or double substitution around the central scaffold dramatically modifies the activity for one or two targets, respectively. The approach introduced in this report can be applied to any analogue series with two biological activity endpoints. To illustrate the approach, we discuss the SAR of 106 pyrrolidine bis-diketopiperazines tested against two formylpeptide receptors obtained from positional scanning deconvolution methods of mixture-based libraries.

[1]  Jürgen Bajorath,et al.  MMP-Cliffs: Systematic Identification of Activity Cliffs on the Basis of Matched Molecular Pairs , 2012, J. Chem. Inf. Model..

[2]  Andreas Bender,et al.  How similar are those molecules after all? Use two descriptors and you will have three different answers , 2010, Expert opinion on drug discovery.

[3]  Philip M Murphy,et al.  Formyl-peptide receptors revisited. , 2002, Trends in immunology.

[4]  Dimitris K. Agrafiotis,et al.  Enhanced SAR Maps: Expanding the Data Rendering Capabilities of a Popular Medicinal Chemistry Tool , 2009, J. Chem. Inf. Model..

[5]  Anne Mai Wassermann,et al.  SAR Matrices: Automated Extraction of Information-Rich SAR Tables from Large Compound Data Sets , 2012, J. Chem. Inf. Model..

[6]  Jürgen Bajorath,et al.  Modeling of activity landscapes for drug discovery , 2012, Expert opinion on drug discovery.

[7]  Clemencia Pinilla,et al.  Strategies for the use of mixture-based synthetic combinatorial libraries: scaffold ranking, direct testing in vivo, and enhanced deconvolution by computational methods. , 2008, Journal of combinatorial chemistry.

[8]  Woody Sherman,et al.  Large-Scale Systematic Analysis of 2D Fingerprint Methods and Parameters to Improve Virtual Screening Enrichments , 2010, J. Chem. Inf. Model..

[9]  Rajarshi Guha,et al.  Chemoinformatic Analysis of Combinatorial Libraries, Drugs, Natural Products, and Molecular Libraries Small Molecule Repository , 2009, J. Chem. Inf. Model..

[10]  Dimitris K. Agrafiotis,et al.  Single R-Group Polymorphisms (SRPs) and R-Cliffs: An Intuitive Framework for Analyzing and Visualizing Activity Cliffs in a Single Analog Series , 2011, J. Chem. Inf. Model..

[11]  José L Medina-Franco,et al.  Activity Cliffs: Facts or Artifacts? , 2013, Chemical biology & drug design.

[12]  Philip M. Murphy,et al.  Cutting Edge: The Neurotoxic Prion Peptide Fragment PrP106–126 Is a Chemotactic Agonist for the G Protein-Coupled Receptor Formyl Peptide Receptor-Like 11 2 , 2001, The Journal of Immunology.

[13]  Andrew G. Leach,et al.  Matched molecular pair analysis in drug discovery. , 2013, Drug discovery today.

[14]  X. Bian,et al.  Formylpeptide receptor FPR and the rapid growth of malignant human gliomas. , 2005, Journal of the National Cancer Institute.

[15]  Jürgen Bajorath,et al.  Exploring activity cliffs in medicinal chemistry. , 2012, Journal of medicinal chemistry.

[16]  José L. Medina-Franco,et al.  Scanning Structure-Activity Relationships with Structure-Activity Similarity and Related Maps: From Consensus Activity Cliffs to Selectivity Switches , 2012, J. Chem. Inf. Model..

[17]  Clemencia Pinilla,et al.  Advances in the use of synthetic combinatorial chemistry: Mixture-based libraries , 2003, Nature Medicine.

[18]  David Rogers,et al.  Extended-Connectivity Fingerprints , 2010, J. Chem. Inf. Model..

[19]  J. Medina-Franco,et al.  Expanding the medicinally relevant chemical space with compound libraries. , 2012, Drug discovery today.

[20]  José L. Medina-Franco,et al.  Consensus Models of Activity Landscapes with Multiple Chemical, Conformer, and Property Representations , 2011, J. Chem. Inf. Model..

[21]  José L. Medina-Franco,et al.  Structure–activity relationships of benzimidazole derivatives as antiparasitic agents: Dual activity-difference (DAD) maps , 2011 .

[22]  Jaime Pérez-Villanueva,et al.  Towards a systematic characterization of the antiprotozoal activity landscape of benzimidazole derivatives. , 2010, Bioorganic & medicinal chemistry.

[23]  Clemencia Pinilla,et al.  Selective Agonists and Antagonists of Formylpeptide Receptors: Duplex Flow Cytometry and Mixture-Based Positional Scanning Libraries , 2013, Molecular Pharmacology.

[24]  J. Medina-Franco,et al.  Shifting from the single to the multitarget paradigm in drug discovery. , 2013, Drug discovery today.

[25]  Jaime Pérez-Villanueva,et al.  Activity landscape modeling of PPAR ligands with dual-activity difference maps. , 2012, Bioorganic & medicinal chemistry.

[26]  Hélène Decornez,et al.  Early phase drug discovery: cheminformatics and computational techniques in identifying lead series. , 2012, Bioorganic & medicinal chemistry.

[27]  Dimitris K. Agrafiotis,et al.  Efficient Substructure Searching of Large Chemical Libraries: The ABCD Chemical Cartridge , 2011, J. Chem. Inf. Model..

[28]  Austin B. Yongye,et al.  Multitarget Structure-Activity Relationships Characterized by Activity-Difference Maps and Consensus Similarity Measure , 2011, J. Chem. Inf. Model..

[29]  R A Houghten,et al.  Mixture-based synthetic combinatorial libraries. , 1999, Journal of medicinal chemistry.

[30]  Jaime Pérez-Villanueva,et al.  CASE Plots for the Chemotype‐Based Activity and Selectivity Analysis: A CASE Study of Cyclooxygenase Inhibitors , 2012, Chemical biology & drug design.

[31]  José L. Medina-Franco,et al.  Characterization of Activity Landscapes Using 2D and 3D Similarity Methods: Consensus Activity Cliffs , 2009, J. Chem. Inf. Model..